Serveur d'exploration autour de Joseph Jankovic - Curation (Ncbi)

Index « Mesh.i » - entrée « Drug Therapy, Combination »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Synergism < Drug Therapy, Combination < Dysarthria  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000017 (2000) W. Ondo [États-Unis] ; D. Warrior ; A. Overby ; J. Calmes ; N. Hendersen ; S. Olson ; Joseph Jankovic [États-Unis]Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
000134 (2006) Aleksandar. Risti [Serbie] ; Nikola Vojvodi ; Slavko Jankovi ; Aleksandra Sindeli ; Dragoslav SokiThe frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
000289 (2010) Fabrizio Stocchi [Italie] ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa ; Paulo Barone ; Anthony. Lang ; C OlanowInitiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
000407 (2014) José Baizabal [États-Unis] ; Joseph Jankovic [États-Unis]Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.
000559 (1987) Joseph Jankovic [États-Unis] ; J. OrmanParallel double-blind study of pergolide in Parkinson's disease.
000564 (1985) Joseph Jankovic [États-Unis]Long-term use of dopamine agonists in Parkinson's disease.
000589 (1995) M Mcdermott [États-Unis] ; Joseph Jankovic [États-Unis] ; J. Carter ; S. Fahn ; S. Gauthier ; C Goetz ; L Golbe ; W. Koller ; A Lang ; C OlanowFactors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
000596 (1994) C Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J Grimes ; Joseph Jankovic [États-Unis]A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Drug Therapy, Combination" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Therapy, Combination
}}

Wicri

This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024